Crestor (rosuvastatin calcium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
CONTRAINDICATIONS
Replace bullets 3 and 4 with the following:
Pregnancy
Lactation. Limited data indicate... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Zorvolex (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Zipsor (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren-XR (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren Gel (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Vioxx (rofecoxib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Vimovo (naproxen/esomeprazole magnesium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Treximet (naproxen and sumitriptan)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Tivorbex (indomethacin)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Sprix (ketorolac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Solaraze (diclofenac sodium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Potiga (ezogabine)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
BOXED WARNING
damage to the photoreceptors and vision loss… Macular abnormalities characterized as vitelliform lesions... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Ponstel (mefenamic acid)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Xalkori (crizotinib) Capsules, for Oral Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
ADVERSE REACTIONS
Clinical Trials Experience
Renal impairment
The estimated glomerular filtration... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - April 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
